The results of the EVOKE and EVOKE+ trials were comprehensive in showing oral semaglutide’s lack of clinical efficacy for ...

Power usage by AI and data center systems in the U.S. is extraordinary by any measure. The International Energy Agency estimates U.S. AI and data ...

Depression screening predicts subsequent disability progression in people with primary progressive multiple sclerosis.

For decades, one of the greatest challenges to treating neurological disorders like attention-deficit/hyperactivity disorder ...

Greater early symptom burden after mild TBI is associated with a lack of improvement in post-traumatic headache outcomes.

People on highest PIP or Adult Disability Payment due up to £778 a month this year READ MORE: People with PIP mobility award could see eligibility changes before end o ...

A practical guide to choosing a brain tumor center, navigating seizure‑related care, and using key questions to shape a thoughtful, confident path forward.

How ESA and State Grants Unlock Elite Special Needs Homeschool Tutoring The financial barrier to high-quality education is ...

The 7 mg dose of OV329 demonstrated favorable safety and tolerability profile, reinforcing best-in-category potential for ...

A new discovery by McGill researchers sheds light on how we retain memories over time, even though brain activity is constantly changing.Published in ...

DOC1021 is a first-in-class, patient-derived double-loaded dendritic cell therapy that combines tumor lysate and amplified tumor-derived mRNA. The immunotherapy is made with a patient's dendritic ...

Rising detection of pituitary incidentalomas has prompted a more individualized approach to surveillance and management.Incidentalomas are being found with greater frequency than in the past, ...